OPTN
OptiNose
OPTN
OPTN
Delisted
OPTN was delisted on the 20th of May, 2025.
72 hedge funds and large institutions have $543M invested in OptiNose in 2018 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 36 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
72
Holders Change
+23
Holders Change %
+46.94%
% of All Funds
1.65%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
28
Increased
36
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
JPMorgan Chase & Co
New York
|
$37.7M |
| 2 |
BlackRock
New York
|
$27.9M |
| 3 |
Franklin Resources
San Mateo,
California
|
$17M |
| 4 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
$16.3M |
| 5 |
TA
Tamarack Advisers
Carlsbad,
California
|
$17.5M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
OAM
76
Oxford Asset Management
Oxford,
United Kingdom
| – | -$1.5M | -4,988 | Closed |
|
|
IBT
77
International Biotechnology Trust
London,
United Kingdom
| – | -$1.3M | -4,333 | Closed |
|
78
Macquarie Group
Sydney, NSW 2000,
Australia
| – | -$538K | -1,790 | Closed |
|